CompletedPhase 4NCT02526550

Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX

Studying Encephalitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Siriraj Hospital
Principal Investigator
Kulkanya Chokephaibulkit, Professor
Siriraj Hospital
Intervention
Live attenuated chimeric Japanese Encephalitis vaccine(biological)
Enrollment
50 enrolled
Eligibility
1-5 years · All sexes
Timeline
2014 – 2014

Collaborators

Sanofi Pasteur, a Sanofi Company

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02526550 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis →

← Back to all trials